JPH0578312B2 - - Google Patents
Info
- Publication number
- JPH0578312B2 JPH0578312B2 JP14416885A JP14416885A JPH0578312B2 JP H0578312 B2 JPH0578312 B2 JP H0578312B2 JP 14416885 A JP14416885 A JP 14416885A JP 14416885 A JP14416885 A JP 14416885A JP H0578312 B2 JPH0578312 B2 JP H0578312B2
- Authority
- JP
- Japan
- Prior art keywords
- sod
- reagent
- same
- sod activity
- absorbance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 102000019197 Superoxide Dismutase Human genes 0.000 claims description 38
- 108010012715 Superoxide dismutase Proteins 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 32
- 230000000694 effects Effects 0.000 claims description 25
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 8
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 claims description 7
- 108091006149 Electron carriers Proteins 0.000 claims description 6
- 238000005259 measurement Methods 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 claims description 4
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 4
- 239000000758 substrate Substances 0.000 claims description 4
- 238000000691 measurement method Methods 0.000 claims description 3
- 150000001728 carbonyl compounds Chemical class 0.000 claims description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 2
- 125000003545 alkoxy group Chemical group 0.000 claims 1
- 125000000542 sulfonic acid group Chemical group 0.000 claims 1
- 239000003153 chemical reaction reagent Substances 0.000 description 31
- 239000012085 test solution Substances 0.000 description 20
- 238000002835 absorbance Methods 0.000 description 18
- 239000000243 solution Substances 0.000 description 14
- LRFVTYWOQMYALW-UHFFFAOYSA-N 9H-xanthine Chemical compound O=C1NC(=O)NC2=C1NC=N2 LRFVTYWOQMYALW-UHFFFAOYSA-N 0.000 description 12
- 230000000052 comparative effect Effects 0.000 description 10
- 239000000203 mixture Substances 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 229940075420 xanthine Drugs 0.000 description 6
- 238000011088 calibration curve Methods 0.000 description 5
- 108010093894 Xanthine oxidase Proteins 0.000 description 4
- 102100033220 Xanthine oxidase Human genes 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- MASUWVVNWALEEM-UHFFFAOYSA-M 1-methoxy-5-methylphenazin-5-ium;methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2N=C3C(OC)=CC=CC3=[N+](C)C2=C1 MASUWVVNWALEEM-UHFFFAOYSA-M 0.000 description 2
- RLFWWDJHLFCNIJ-UHFFFAOYSA-N 4-aminoantipyrine Chemical compound CN1C(C)=C(N)C(=O)N1C1=CC=CC=C1 RLFWWDJHLFCNIJ-UHFFFAOYSA-N 0.000 description 2
- 102000003992 Peroxidases Human genes 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000007983 Tris buffer Substances 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000007323 disproportionation reaction Methods 0.000 description 2
- 108040007629 peroxidase activity proteins Proteins 0.000 description 2
- XXQBEVHPUKOQEO-UHFFFAOYSA-N potassium superoxide Chemical compound [K+].[K+].[O-][O-] XXQBEVHPUKOQEO-UHFFFAOYSA-N 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- IRQRBVOQGUPTLG-UHFFFAOYSA-M sodium;3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonate Chemical compound [Na+].[O-]S(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 IRQRBVOQGUPTLG-UHFFFAOYSA-M 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- UCTWMZQNUQWSLP-VIFPVBQESA-N (R)-adrenaline Chemical compound CNC[C@H](O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-VIFPVBQESA-N 0.000 description 1
- 229930182837 (R)-adrenaline Natural products 0.000 description 1
- 150000003923 2,5-pyrrolediones Chemical class 0.000 description 1
- ZTQGWROHRVYSPW-UHFFFAOYSA-N 3-(n-ethyl-3-methylanilino)-2-hydroxypropane-1-sulfonic acid Chemical compound OS(=O)(=O)CC(O)CN(CC)C1=CC=CC(C)=C1 ZTQGWROHRVYSPW-UHFFFAOYSA-N 0.000 description 1
- 208000005623 Carcinogenesis Diseases 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PEEHTFAAVSWFBL-UHFFFAOYSA-N Maleimide Chemical compound O=C1NC(=O)C=C1 PEEHTFAAVSWFBL-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000036952 cancer formation Effects 0.000 description 1
- 231100000504 carcinogenesis Toxicity 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 229960005139 epinephrine Drugs 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- FSVCQIDHPKZJSO-UHFFFAOYSA-L nitro blue tetrazolium dichloride Chemical compound [Cl-].[Cl-].COC1=CC(C=2C=C(OC)C(=CC=2)[N+]=2N(N=C(N=2)C=2C=CC=CC=2)C=2C=CC(=CC=2)[N+]([O-])=O)=CC=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=C([N+]([O-])=O)C=C1 FSVCQIDHPKZJSO-UHFFFAOYSA-L 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- DIVDFFZHCJEHGG-UHFFFAOYSA-N oxidopamine Chemical compound NCCC1=CC(O)=C(O)C=C1O DIVDFFZHCJEHGG-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- CXVGEDCSTKKODG-UHFFFAOYSA-N sulisobenzone Chemical compound C1=C(S(O)(=O)=O)C(OC)=CC(O)=C1C(=O)C1=CC=CC=C1 CXVGEDCSTKKODG-UHFFFAOYSA-N 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14416885A JPS623799A (ja) | 1985-06-29 | 1985-06-29 | ス−パ−オキシドジスムタ−ゼ活性測定法 |
| CA000502824A CA1272943A (en) | 1985-03-01 | 1986-02-27 | Process for determining superoxide dismutase activity |
| US06/834,971 US4801538A (en) | 1985-03-01 | 1986-02-28 | Process for determining superoxide dismutase activity |
| AT86102657T ATE54169T1 (de) | 1985-03-01 | 1986-02-28 | Verfahren zur bestimmung der superoxid-dismutase- aktivitaet. |
| EP86102657A EP0193204B1 (en) | 1985-03-01 | 1986-02-28 | Process for determining superoxide dismutase activity |
| DE8686102657T DE3672272D1 (de) | 1985-03-01 | 1986-02-28 | Verfahren zur bestimmung der superoxid-dismutase-aktivitaet. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14416885A JPS623799A (ja) | 1985-06-29 | 1985-06-29 | ス−パ−オキシドジスムタ−ゼ活性測定法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS623799A JPS623799A (ja) | 1987-01-09 |
| JPH0578312B2 true JPH0578312B2 (cs) | 1993-10-28 |
Family
ID=15355779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP14416885A Granted JPS623799A (ja) | 1985-03-01 | 1985-06-29 | ス−パ−オキシドジスムタ−ゼ活性測定法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS623799A (cs) |
-
1985
- 1985-06-29 JP JP14416885A patent/JPS623799A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS623799A (ja) | 1987-01-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Kageyama | A direct colorimetric determination of uric acid in serum and urine with uricase-catalase system | |
| Matsubara et al. | Spectrophotometric determination of hydrogen peroxide with titanium 2-((5-bromopyridyl) azo)-5-(N-propyl-N-sulfopropylamino) phenol reagent and its application to the determination of serum glucose using glucose oxidase | |
| JPS5886083A (ja) | グリセロ−ル−３−リン酸オキシダ−ゼの安定化剤 | |
| JPH0577399B2 (cs) | ||
| JPH11504808A (ja) | 糖化タンパク質の測定 | |
| JPS60184400A (ja) | 新規な発色試薬 | |
| US4143080A (en) | Method and reagent for the assay of hydroperoxide | |
| JP2854995B2 (ja) | 尿酸測定用試薬組成物 | |
| KINOSHITA et al. | A fluorophotometric determination of serum creatinine and creatine using a creatinineamidohydrolase-creatineamidinohydrolase-sarcosine oxidase-peroxidase system and diacetyldichlorofluorescin | |
| EP0193204B1 (en) | Process for determining superoxide dismutase activity | |
| KR100312056B1 (ko) | 아스코르브산의정량방법및정량용시약 | |
| JP4022799B2 (ja) | 電解質測定用試薬組成物 | |
| JPH07155196A (ja) | 生体成分の測定法 | |
| JPH03502281A (ja) | 溶液状態のビリルビンの測定方法 | |
| Asp | Improved method for the assay of phenylglycosidase activity with a 4-aminoantipyrine reagent | |
| JPH0578312B2 (cs) | ||
| KR100379646B1 (ko) | 시약 조성물, 시험편 및 측정 키트 | |
| JP2994831B2 (ja) | コレステロールの定量法および定量用試薬 | |
| CS227331B2 (en) | Method of glycerol determination | |
| Kuan et al. | An alternative method for the determination of uric acid in serum | |
| JPS62175197A (ja) | Ｌ−フコ−スの定量方法 | |
| JP2008295305A (ja) | 糖化アルブミン測定試薬 | |
| JPS6349081A (ja) | アスコルビン酸オキシダ−ゼの安定化法 | |
| JP4544598B2 (ja) | 液状試薬および保存方法 | |
| JP3097370B2 (ja) | 過酸化水素の測定方法 |